S&P 500
$5,791.67
-0.9%
-$50.34
DJI
$41,553.96
-0.7%
-$305.13
NASDAQ
$18,723.71
-1.1%
-$202.03
Bitcoin
109,796.00
-1.0%
-1,135.35
AAPL
$197.40
-2.0%
-$3.96
AMZN
$201.10
-1.0%
-$2.00
GOOG
$170.26
-1.0%
-$1.72
META
$629.17
-1.2%
-$7.40
MSFT
$451.53
-0.7%
-$3.33
NVDA
$130.50
-1.8%
-$2.33
TSLA
$335.95
-1.5%
-$5.09
Free Analysis
Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research
Myomo (NYSEMKT: MYO)
$3.11
(-3.1%)
-$0.10
Price as of May 23, 2025, 10:23 a.m. ET
Myomo Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Myomo Company Info
Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. It offers MyoPro, an upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.